Use of granulocyte colony stimulating factor (G-CSF)-mobilized peripheral blood
hematopoietic progenitor cells (HPCs) has largely replaced bone marrow (BM) as a source …

The use of mobilized peripheral blood stem cells (PBSCs) has largely replaced the use of
bone marrow as a source of stem cells for both allogeneic and autologous stem cell …

Peripheral blood stem cells (PBSC) have nearly replaced bone marrow (BM) as the
preferred source of hematopoietic rescue for patients undergoing high-dose chemotherapy …

Abstract Transplantation with 2-5× 106 mobilized CD34+ cells/kg body weight lowers
transplantation costs and mortality. Mobilization is most commonly performed with …

HSC mobilization induced by granulocyte colony-stimulating factor may be enhanced by
directly targeting the chemotactic interaction between HSCs and bone marrow stroma with …

In autologous stem cell transplantation, mobilized peripheral blood has replaced the bone
marrow as the preferred source of hematopoietic stem cells (HSCs). Because HSCs …

Mobilized peripheral blood stem cells (PBSC) have become the main source for autologous
or allogeneic transplantation following myeloablative therapy in patients with …

Mobilized peripheral blood (PB) is the most common source of hematopoietic stem cells
(HSC) for autologous transplantation. Granulocyte colony stimulating factor (G-CSF) is the …

Successful hematopoietic stem cell transplant requires the infusion of a sufficient number of
hematopoietic stem/progenitor cells (HSPCs) that are capable of homing to the bone marrow …

In spite of the safety and efficiency of the classical mobilization protocols, recombinant
human G-CSF±chemotherapy, there is still a considerable amount of mobilization failures …